Prevalencia de la multidrogorresistencia en pacientes con tuberculosis pulmonar atendidos en el Hospital General Guasmo Sur durante el período de enero del 2019 a junio del 2021.

Abstract

Tuberculosis is caused by Mycobacterium tuberculosis and is one of the main causes of morbidity and mortality worldwide. General objective: To determine the prevalence of multidrug resistance in patients with pulmonary tuberculosis treated at the Guasmo Sur General Hospital from January 2019 to June 2021. Materials and methods: observational, retrospective, descriptive and prevalence study. It is based on the quantitative method, of an epidemiological nature, since we collected data from the Guasmo Sur General Hospital, to analyze them quantitatively according to variables to obtain accurate conclusions. Results: Our universe is 1282 patients with pulmonary tuberculosis, 90% are not MDR, 7% are MDR/RR and 3% are MDR patients. The predominant sex in the study period is male with 88% versus 12% in women. According to the age group, the highest percentage corresponded to patients between 31 and 50 years old, with 41% of the total. 33% of MDR patients were between 18 to 30 years old, 21% between 51 to 70 years old and 5% were older than 70 years. Conclusion: The prevalence of multidrugresistant pulmonary tuberculosis in the Guasmo Sur General Hospital in the period from January 2019 to June 2021, has been increasing in recent years, and was particularly evident in the year 2021, where the cases of patients resistant to multiple drugs increased. such as rifampin and isoniazid. Double drug resistance is more common than resistance to more than 3 or 4 or more.